| [1] |
乔志勇, 陈万收, 李帅康. 腹腔镜手术治疗结肠癌患者的临床疗效[J]. 医学临床研究, 2025, 42(9):1611-1613.
|
|
Qiao Z Y, Chen W S, Li S K. Clinical efficacy of laparoscopic surgery in the treatment of patients with colon cancer[J]. Journal of Clinical Research, 2025, 42(9):1611-1613. doi:10.3969/j.issn.1671-7171.2025.09.035.
|
| [2] |
魏晓为, 张琳珠, 张娟, 等. CONUT评分对Ⅱ/Ⅲ期老年结肠癌病人术后辅助化疗耐受性及预后的预测研究[J]. 实用老年医学, 2025, 39(3):241-244.
|
|
Wei X W, Zhang L Z, Zhang J, et al. Predictive study of CONUT score on adjuvant chemotherapy tolerance and prognosis in elderly patients with stage Ⅱ/Ⅲ colon cancer after surgery[J]. Practical Geriatrics, 2025, 39(3):241-244. doi:10.3969/j.issn.1003-9198.2025.03.006.
|
| [3] |
马红玉, 曹琳, 刘爽, 等. 多参数MRI联合炎症因子指标对乳腺癌肿瘤浸润淋巴细胞的预测价值[J]. 临床放射学杂志, 2025, 44(2):259-265.
|
|
Ma H Y, Cao L, Liu S, et al. Predictive value of multi-parameter MRI combined with inflammatory markers for tumor-infiltrating lymphocytes in breast cancer[J]. Journal of Clinical Radiology, 2025, 44(2):259-265. doi:10.13437/j.cnki.jcr.2025.02.012.
|
| [4] |
汤晓青, 郭玺, 万焱, 等. PPI指数联合NLR LMR PLR预测晚期结直肠癌患者生存预后的价值分析[J]. 河北医学, 2025, 31(2):320-326.
|
|
Tang X Q, Guo X, Wan Y, et al. Value of PPI index combined with NLR,LMR and PLR in predicting survival prognosis of patients with advanced colorectal cancer[J]. Hebei Medicine, 2025, 31(2):320-326. doi:10.3969/j.issn.1006-6233.2025.02.026.
|
| [5] |
郑慧, 陈颖秀, 叶绿茵, 等. 结直肠癌患者外周血T淋巴细胞亚群与肿瘤进展的关系[J]. 检验医学, 2024, 39(4):330-335.
|
|
Zheng H, Chen Y X, Ye L Y, et al. Relationship between peripheral blood T lymphocyte subsets and tumor progression in patients with colorectal cancer[J]. Laboratory Medicine, 2024, 39(4):330-335. doi:10.3969/j.issn.1673-8640.2024.04.004.
|
| [6] |
韩安家, 黄艳, 来茂德. 肿瘤病理诊断规范(结直肠癌)[J]. 中华病理学杂志, 2016, 45(12):822-824.
|
|
Han A J, Huang Y, Lai M D. Diagnostic criteria for tumor pathology (colorectal cancer)[J]. Chinese Journal of Pathology, 2016, 45(12):822-824. doi:10.3760/cma.j.issn.0529-5807.2016.12.002.
|
| [7] |
Amin M B, Greene F L, Edge S B, et al. The Eighth Edition AJCC Cancer Staging Manual:Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging[J]. CA Cancer J Clin, 2017, 67(2):93-99. doi:10.3322/caac.21388.
|
| [8] |
张泽群, 龙飞, 胡桂, 等. 2021年V2版NCCN结肠癌临床实践指南更新解读[J]. 临床外科杂志, 2022, 30(1):16-19.
|
|
Zhang Z Q, Long F, Hu G, et al. Interpretation of NCCN clinical practice guidelines for colon cancer(version 2.2021)[J]. Journal of Clinical Surgery, 2022, 30(1):16-19. doi:10.3969/j.issn.1005-6483.2022.01.006.
|
| [9] |
刘松, 翟晓羽, 张彬, 等. 腹腔镜结肠癌根治术对老年结肠癌患者的炎性因子、血清应激指标及免疫功能的影响[J]. 老年医学与保健, 2021, 27(2):253-256.
|
|
Liu S, Zhai X Y, Zhang B, et al. Effects of laparoscopic radical resection of colon cancer on inflammatory factors,serum stress indicators and immune function in elderly patients with colon cancer[J]. Geriatrics & Health Care, 2021, 27(2):253-256. doi:10.3969/j.issn.1008-8296.2021.02.012.
|
| [10] |
德琳, 顾佩菲, 窦琴, 等. 谷氨酰胺强化肠内营养对结肠癌患者术后营养指标、免疫及炎性反应的影响[J]. 中国肿瘤临床与康复, 2020, 27(8):925-928.
|
|
De L, Gu P F, Dou Q, et al. Effects of glutamine-enhanced enteral nutrition on postoperative nutritional indicators,immunity and inflammatory response in patients with colon cancer[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2020, 27(8):925-928.
|
| [11] |
陈荧野, 陈勇, 姜庆, 等. NLR及PLR对晚期尿路上皮癌免疫治疗疗效和预后的预测价值[J]. 重庆医科大学学报, 2023, 48(8):965-970.
|
|
Chen Y Y, Chen Y, Jiang Q, et al. Predictive value of NLR and PLR for efficacy and prognosis of immunotherapy in advanced urothelial carcinoma[J]. Journal of Chongqing Medical University, 2023, 48(8):965-970. doi:10.13406/j.cnki.cyxb.003317.
|
| [12] |
Yan W, Ou X, Shen C, et al. A nomogram involving immune-inflammation index for predicting distant metastasis-free survival of major salivary gland carcinoma following postoperative radiotherapy[J]. Cancer Med, 2023, 12(3):2772-2781. doi:10.1002/cam4.5167.
|
| [13] |
Ding P, Yang J, Wu J, et al. Combined systemic inflammatory immune index and prognostic nutrition index as chemosensitivity and prognostic markers for locally advanced gastric cancer receiving neoadjuvant chemotherapy:a retrospective study[J]. BMC Cancer, 2024, 24(1):1014. doi:10.1186/s12885-024-12678-3.
|
| [14] |
候玥, 王燕, 蔡静. 髓源抑制细胞水平及外周血NLR和PLR比值在结肠癌中的意义[J]. 肿瘤学杂志, 2020, 26(8):706-709.
|
|
Hou Y, Wang Y, Cai J. Significance of myeloid-derived suppressor cells level and peripheral blood NLR and PLR ratios in colon cancer[J]. Journal of Oncology, 2020, 26(8):706-709. doi:10.11735/j.issn.1671-170X.2020.08.B009.
|
| [15] |
盛俊, 武翔. XELOX方案与FOLFOX4方案治疗结肠癌效果及对血清肿瘤标志物和细胞学指标的影响[J]. 肿瘤研究与临床, 2021, 33(5):353-358.
|
|
Sheng J, Wu X. Effect of XELOX regimen and FOLFOX4 regimen on colon cancer and their influence on serum tumor markers and cytological indicators[J]. Cancer Research and Clinic, 2021, 33(5):353-358. doi:10.3760/cma.j.cn115355-20200402-00167.
|
| [16] |
张丽柯, 马磊, 史芳瑜, 等. 胃癌组织细胞程序性死亡配体1表达情况和CD8+肿瘤浸润T淋巴细胞密度及其与患者临床病理特征和预后的关系研究[J]. 中国全科医学, 2022, 25(18):2262-2267.
|
|
Zhang L K, Ma L, Shi F Y, et al. Expression of PD-L1 and density of CD8+ tumor-infiltrating T lymphocytes in gastric cancer and their association with clinicopathological features and prognosis[J]. Chinese General Practice, 2022, 25(18):2262-2267. doi:10.12114/j.issn.1007-9572.2021.02.080.
|
| [17] |
Osman A, Yan B, Li Y, et al. TCF-1 controls Treg cell functions that regulate inflammation,CD8+ T cell cytotoxicity and severity of colon cancer[J]. Nat Immunol, 2021, 22(9):1152-1162.
|
| [18] |
谭杨波, 梁典胤, 李柳丽. 结直肠癌患者CD4+、CD8+T淋巴细胞介导免疫功能的影响因素[J]. 现代肿瘤医学, 2022, 30(18):3321-3325.
|
|
Tan Y B, Liang D Y, Li L L. Factors influencing CD4+ and CD8+ T lymphocyte-mediated immune function in patients with colorectal cancer[J]. Journal of Modern Oncology, 2022, 30(18):3321-3325. doi:10.3969/j.issn.1672-4992.2022.18.013.
|
| [19] |
阮哲宇, 刘俊杰, 柯毅恒, 等. 术前外周血NLR联合PLR在胰腺癌根治性切除术预后评估中的价值[J]. 肝胆胰外科杂志, 2024, 36(2):70-74.
|
|
Ruan Z Y, Liu J J, Ke Y H, et al. Value of preoperative peripheral blood NLR combined with PLR in prognostic evaluation of pancreatic cancer after radical resection[J]. Journal of Hepatopancreatobiliary Surgery, 2024, 36(2):70-74. doi:10.11952/j.issn.1007-1954.2024.02.002.
|
| [20] |
孙丹, 朱正秋, 邢阿雯. 炎性指标联合循环肿瘤细胞对乳腺癌新辅助化疗疗效的预测价值[J]. 现代肿瘤医学, 2025, 33(6):1002-1006.
|
|
Sun D, Zhu Z Q, Xing A W. Predictive value of inflammatory markers combined with circulating tumor cells for neoadjuvant chemotherapy efficacy in breast cancer[J]. Journal of Modern Oncology, 2025, 33(6):1002-1006. doi:10.3969/j.issn.1672-4992.2025.06.017.
|
| [21] |
于晓洁, 丘木水. CD4+和CD8+T淋巴细胞在结直肠癌诊治中的临床应用[J]. 检验医学与临床, 2021, 18(18):2758-2762.
|
|
Yu X J, Qiu M S. Clinical application of CD4+ and CD8+ T lymphocytes in the diagnosis and treatment of colorectal cancer[J]. Laboratory Medicine and Clinic, 2021, 18(18):2758-2762. doi:10.3969/j.issn.1672-9455.2021.18.037.
|
| [22] |
Escobar G, Tooley K, Oliveras J P, et al. Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapy[J]. Cancer Cell, 2023, 41(9):1662-1679. doi:10.1016/j.ccell.2023.08.001.
|
| [23] |
夏吉凯, 马成, 任超峰. 结直肠癌患者CD4+、CD8+T淋巴细胞水平对预后的影响[J]. 热带医学杂志, 2020, 20(6):810-814.
|
|
Xia J K, Ma C, Ren C F. Effect of CD4+ and CD8+ T lymphocyte levels on prognosis of patients with colorectal cancer[J]. Journal of Tropical Medicine, 2020, 20(6):810-814.
|